Post by ESMO - European Society for Medical Oncology

Final results from the IMPACT study support systematic annual PSA screening in men with #BRCA2 mutations, with higher rates of clinically significant and higher-risk #ProstateCancer detected. Findings also highlight the value of structured #screening in #BRCA1 carriers, while raising important questions on how to further refine risk-adapted screening approaches. 👉 Read the Opinion by Heather H. Cheng, MD PhD in the #ESMODailyReporter ➡️ https://ow.ly/7egi50Z6Eyy #CancerResearch #PrecisionMedicine